Surrogate endpoints for overall survival in metastatic melanoma: a meta-analysis of randomised controlled trials

BACKGROUND: Recent phase 3 trials have shown an overall survival benefit in metastatic melanoma. We aimed to assess whether progression-free survival (PFS) could be regarded as a reliable surrogate for overall survival through a meta-analysis of randomised trials. METHODS: We systematically reviewed...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Lancet Oncol
मुख्य लेखकों: Flaherty, Keith T, Hennig, Michael, Lee, Sandra J, Ascierto, Paolo A, Dummer, Reinhard, Eggermont, Alexander M M, Hauschild, Axel, Kefford, Richard, Kirkwood, John M, Long, Georgina V, Lorigan, Paul, Mackensen, Andreas, McArthur, Grant, O'Day, Steven, Patel, Poulam M, Robert, Caroline, Schadendorf, Dirk
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: 2014
विषय:
Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4443445/
https://ncbi.nlm.nih.gov/pubmed/24485879
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(14)70007-5
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन